Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1452 of 6351
-
Can a Hormone-Radiation combo save erectile function in prostate cancer?
Disease control Recruiting nowThe goal of this study is to evaluate the recovery of erectile function at six months after hormonal therapy cessation in male patients affected by advanced prostate cancer and undergoing radiotherapy. The main questions are: * How well and how quickly do patients recover their …
Phase 2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
AI phone app could spot PTSD in minutes, not hours
Diagnosis Recruiting nowThe goal of the REVEAL PTSD study is to test how well the Senseye DT works as a diagnostic test for Post-traumatic Stress Disorder (PTSD) in adults 18 and older who are experiencing one or more symptoms that might be related to PTSD. The Senseye DT is software as a medical devic…
Phase 3 • Sponsor: Senseye, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New psoriasis drug ORKA-001 tested for Long-Term safety
Disease control Recruiting nowAn open-label extension (OLE) study to evaluate the long-term safety and efficacy of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis, who previously participated in an Oruka Therapeutics sponsored study.
Phase 2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
One-Day HPV test and treatment could cut cervical cancer in women with HIV
Disease control Recruiting nowThis study aims to conduct a randomized controlled trial to evaluate the effectiveness of same-day HPV-based screen and treat among women living with HIV (WLH) in La Romana, Dominican Republic. With cervical cancer being a leading cause of cancer-related deaths in women living wi…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
MRNA flu shots enter human testing – could they beat traditional vaccines?
Vaccine Recruiting nowThe purpose of this study is to learn about safety in participants taking the study vaccine (mRNA-based vaccine) and the ability of the study vaccine to trigger the body's immune response, targeting the flu virus (influenza virus). This study is seeking healthy participants 18 y…
Phase 2 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail takes on rare adrenal cancer
Disease control Recruiting nowThis phase II trial compares the effect of giving cabozantinib with or without cemiplimab in patients with adrenocortical cancer that has spread to nearby tissue or lymph nodes (locally advanced), and that cannot be removed by surgery (unresectable) or that has come back after a …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can an IV boost beat pills for B12 deficiency in kidney dialysis?
Disease control CompletedThe goal of this clinical trial is to learn whether intravenous (IV) vitamin B12 works better than oral vitamin B12 to correct vitamin B12 deficiency in adults on maintenance hemodialysis. The main questions it aims to answer are: Does IV vitamin B12 raise blood B12 levels more …
Sponsor: Jinnah Hospital • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Engineered immune cells take on stubborn blood disorder
Disease control Not yet recruitingThis is an investigator-initiated trial to evaluate the safety and efficacy of universal allogeneic anti-CD19/BCMA CAR T-cells(QT-019C) in Patients With Refractory Primary Immune Thrombocytopenia.
Early phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for IBD patients with anemia: experimental drug enters trial
Disease control Recruiting nowThis is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Phase 2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
First-in-Human trial launches for Off-the-Shelf CAR-NK therapy against tough cancers
Disease control Recruiting nowThis is a Phase I clinical trial being conducted in humans for the first time, aiming to evaluate a novel cell therapy called NEUK203-13 Injection for the treatment of patients with advanced small cell lung cancer (SCLC) who have failed systematic therapy or late stage neuroendoc…
Phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI steps in to settle debate: is new pill combo better than chemo for older leukemia patients?
Knowledge-focused Recruiting nowTo better delineate the contribution of VEN-DEC to the treatment of AML patients aged between ≥ 60 and \< 75 years and deemed fit for Allo-HSCT, real-world data on a patient-level basis will be collected and utilized to generate a matched control cohort of same AML patients treat…
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New drug aims to soften skin and protect lungs in rare disease
Disease control Recruiting nowThe main purpose of the study is to investigate the efficacy on cutaneous thickness and the safety of Nemolizumab in adult patients with systemic sclerosis after a 52-week treatment period and to select the optimal dose for this target population.
Phase 2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New surgical trick could stop arm swelling in breast cancer survivors
Prevention Not yet recruitingBreast cancer surgery that includes removal of lymph nodes from the armpit (axillary lymph node dissection) can disrupt normal lymphatic drainage and may lead to arm swelling, known as lymphedema. This condition can cause discomfort, limit arm function, and reduce quality of life…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
New scan aims to uncover hidden breast cancer in early stage patients
Diagnosis Recruiting nowDCIS (ductal carcinoma in situ) is a common pre-stage for breast cancer. The goal of this clinical trial is to learn if FAPI-PET/MRI (an imaging technique with a weakly radioactive drug) helps to diagnose hidden invasive breast cancer in participants with DCIS. The main question …
Phase 2 • Sponsor: Universität Münster • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
A gentle buzz could be the key to better posture at work
Disease control OngoingThis study aims to investigate the effects of a wearable postural feedback device on scapular muscle endurance, trunk proprioception, thoracic kyphosis angle, and postural awareness in sedentary office workers. A total of 70 sedentary office workers aged 25-45 years will be rando…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Cord blood hope for elderly blood cancer patients
Disease control Not yet recruitingThis trial is a prospective, single-arm, single-center clinical study. A total of 44 elderly (aged 60 to 69 years) patients with hematological malignancies who need to receive a single-unit unrelated umbilical cord blood transplantation (UCBT) are planned to be enrolled. After sc…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Gene test could make leukemia treatment safer for kids
Disease control Not yet recruitingThis is a prospective, single-center clinical study to evaluate the safety and efficacy of a personalized 6-mercaptopurine (6-MP) dosing strategy guided by NUDT15 and TPMT genotypes in children with Acute Lymphoblastic Leukemia (ALL) during maintenance therapy. The study compares…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill shows promise against resistant cancers in early trial
Disease control Recruiting nowTSL2109 is a novel CDK4/6-DYRK2 dual-target inhibitor developed by Jiangsu Tasly Diyee Pharmaceutical Co., Ltd. for solid tumor treatment. Preclinical studies confirm its selective targeting of CDK4/6 and DYRK2, a eukaryotic CMGC family kinase. In palbociclib-resistant cell line…
Phase 1 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Sham surgery showdown: is the knife worth it for sciatica?
Symptom relief Recruiting nowThe FINDISC trial studies whether common back operation, microdiscectomy, is effective and safe for treating sciatica caused by a lumbar disc herniation. The study includes people whose leg pain has not improved after at least six weeks of non-surgical treatment. The FINDISC tri…
Sponsor: Helsinki University Central Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New nerve block could replace needle in the back for spinal headaches
Symptom relief Recruiting nowPost-dural puncture headache (PDPH) is an iatrogenic complication following a dural puncture, which may occur after lumbar puncture, spinal or epidural anesthesia. These headaches are defined as positional headaches, which worsen in the upright position and improve in the supine …
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC